Company Filing History:
Years Active: 1989
Title: Pierre Laboute: Innovator in Biologically Active Substances
Introduction
Pierre Laboute is a notable inventor based in Noumea, France. He has made significant contributions to the field of biologically active substances. His work focuses on the extraction and application of new compounds with potential therapeutic benefits.
Latest Patents
Pierre Laboute holds a patent for a new biologically active substance called girolline. This substance, which can be extracted from the Pseudaxinyssa cantharella sponge, has remarkable antitumor properties. The formula for girolline is represented as ##STR1##. This innovation highlights the potential of marine organisms in developing new medical treatments.
Career Highlights
Pierre Laboute is associated with Rhone-Poulenc Santé, a company known for its commitment to health and pharmaceutical advancements. His work at the company has allowed him to explore the therapeutic applications of natural substances. His research has contributed to the understanding of how certain compounds can be utilized in cancer treatment.
Collaborations
Throughout his career, Pierre has collaborated with notable colleagues such as Alain Ahond and Dominique Laurent. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Pierre Laboute's contributions to the field of biologically active substances, particularly through his patent for girolline, demonstrate the importance of research in discovering new therapeutic agents. His work continues to inspire advancements in medical science.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.